Results 261 to 270 of about 125,690 (294)

Single‐Cell Transcriptomic Reveals the Involvement of Cell–Cell Junctions in the Early Development of Hypertrophic Cardiomyopathy

Dingchen Wang, Lin Miao, Ruobing Wang, Xiaoran Huang, Yaowen Liang, Xiran Wang, Yuge Chen, Yunfei Gao, Huiming Guo, Huiying Liang, Xin Li   +10 more
openalex   +1 more source

Isorhythmic atrioventricular dissociation during anaesthesia in a cat

Veterinary Record Case Reports, Volume 13, Issue 4, December 2025.
Abstract A 10‐year‐old, male, neutered domestic shorthair cat with suspected hypertrophic cardiomyopathy was referred for cystotomy to remove uroliths present in its urinary bladder. Fifteen minutes after induction of general anaesthesia, atrioventricular dissociation was noted on the electrocardiogram with similar atrial and ventricular firing rates ...
Gemma Padrosa Sala, Cristian Cabellos Clemente, Paul Wotton, Frane Ivasovic   +3 more
wiley   +1 more source

Management of Malignant Arrhythmia in Apical Hypertrophic Cardiomyopathy: A Case Report. [PDF]

Am J Case Rep
Acharya R, Gutierrez-Sierra G, Prakash V, Acharya S, Murali S, Abolbashari M.   +5 more
europepmc   +1 more source

Resolution of pancytopenia in a dog infected with Bartonella rochalimae in association with antibiotic therapy

Veterinary Record Case Reports, Volume 13, Issue 4, December 2025.
Abstract Fever, non‐regenerative anaemia and leukopenia were documented in a 7‐year‐old, entire, male Akita Inu dog. The serum biochemistry and urinalysis were unremarkable. Tests for infectious agents were negative, except for SNAP 4Dx seropositive for Anaplasma phagocytophilum or A. platys. PCR for Anaplasma spp. was negative.
Clàudia Viñeta, Javier Martínez‐Caro, Edward B. Breitschwerdt, Josep Pastor, Xavier Roura   +4 more
wiley   +1 more source

Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: Clinical Advances and Therapeutic Prospects. [PDF]

Drug Des Devel Ther
Hou L, Lin B, Ji X, Huang A.
europepmc   +1 more source

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy [PDF]

, 2017
Canter, Charles, et al,
core   +1 more source

Mitochondrial Dysfunction Contributes to Decompensation in a Zebrafish Model of Isoproterenol‐Induced Heart Failure

Acta Physiologica, Volume 241, Issue 12, December 2025.
ABSTRACT Aim Heart failure is a clinical syndrome where the heart's structural or functional impairment leads to inadequate blood flow to meet the body's metabolic demands. Mitochondrial dysfunction is increasingly recognized as a central contributor underlying the contractile impairment observed in the failing heart.
Manuel Vicente, Aaron García‐Blázquez, Antonio Martínez‐Sielva, Jussep Salgado‐Almario, Joaquín Jordán, Beatriz Domingo, Juan Llopis   +6 more
wiley   +1 more source

Emerging technologies for septal reduction therapy in hypertrophic cardiomyopathy. [PDF]

Chin Med J (Engl)
Zhang Y, Zhang X, Zhao Z.
europepmc   +1 more source

Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons

Annals of Clinical and Translational Neurology, Volume 12, Issue 11, Page 2335-2348, November 2025.
ABSTRACT Objectives This ongoing, open‐label extension study is evaluating the long‐term safety, tolerability, and efficacy of givinostat, a Class I and II histone deacetylase inhibitor, in patients with Duchenne muscular dystrophy (DMD). Methods The recruited patients completed one of two prior clinical studies (one Phase 2 and one Phase 3 [EPIDYS ...
Craig M. McDonald, Michela Guglieri, Dragana Vučinić, Gyula Acsadi, John F. Brandsema, Claudio Bruno, Erika L. Finanger, Amy Harper, Mercedes Lopez Lobato, Riccardo Masson, Nuria Muelas, Francina Munell, Yoram Nevo, Yann Péréon, Han Phan, Valeria A. Sansone, Mariacristina Scoto, Tracey Willis, Richard S. Finkel, Krista Vandenborne, Sara Cazzaniga, Silvia Montrasio, Federica Alessi, Paolo Bettica, Eugenio Mercuri, for the Givinostat Study 51 Investigators, the Cooperative International Neuromuscular Research Group (CINRG) Duchenne Natural History Study (DNHS) Investigators, the ImagingDMD Investigators, Enrico Bertini, Giacomo Pietro Comi, Eugenio Maria Mercuri, Giuseppe Vita, Sonia Messina, Claudio Bruno, Riccardo Masson, Valeria Sansone, Nathalie Goemans, Liesbeth De Waele, Laurent Servais, Teresa Gidaro, Odile Boespflug‐Tanguy, Yann Péréon, Jessika Johannsen, Astrid Blaschek, Ulrike Schara‐Schmidt, Erik Niks, Imelda de Groot, Saskia Houwen‐van Opstal, Andres Nascimento, Juan Jesus Vilchez, Nuria Muelas, Francina Munell, Marcos Madruga Garrido, Mercedes Lopez Lobato, Michaela Guglieri, Tracey Willis, Stefan Spinty, Daniel Hawcutt, Mariacristina Scoto, Jean K. Mah, Laura McAdam, Kathryn Selby, Katherine Mathews, Craig McDonald, Craig Zaidman, Barry Byrne, John Brandsema, Gyula Acsadi, Chamindra Laverty, Amy Harper, Erika Finanger, Han Phan, Yoram Nevo, Vedrana Milic Rasic, Dragana Vucinic   +74 more
wiley   +1 more source

Diagnostic Ambiguity in Apical Hypertrophic Cardiomyopathy: Case-Based Insights and Review of Evolving Criteria. [PDF]

JACC Case Rep
Li-Jedras M, Hegazy Y, Abdul Jabbar AB, El-Shaer A, Ghallab M, Kabach A.   +5 more
europepmc   +1 more source